Search research articles
Contact Us
Filters
Showing results (31-40 of 79) with videos related to
Page
of 8
Sort By:
Journal of Neurochemistry
|
June 12, 2023
Proteomics of the astrocyte secretome reveals changes in their response to soluble oligomeric Aβ
Vittoria Matafora, Alena Gorb, Fangjia Yang, et al.
Human Molecular Genetics
|
July 5, 2013
Loss of c-Jun N-terminal kinase-interacting protein-1 does not affect axonal transport of the amyloid precursor protein or Aβ production
Alessio Vagnoni, Elizabeth B C Glennon, Michael S Perkinton, et al.
Molecular Brain
|
January 30, 2015
Evidence that the presynaptic vesicle protein CSPalpha is a key player in synaptic degeneration and protection in Alzheimer's disease
Sachin S Tiwari, Marie d'Orange, Claire Troakes, et al.
Iscience
|
June 30, 2025
Alzheimer's disease brain-derived tau extracts show differential processing and transcriptional effects in human astrocytes
Matthew J Reid, Melissa Leija Salazar, Claire Troakes, et al.
Iscience
|
May 7, 2026
Erratum: Alzheimer's disease brain-derived tau extracts show differential processing and transcriptional effects in human astrocytes
Matthew J Reid, Melissa Leija Salazar, Claire Troakes, et al.
Cellular and Molecular Life Sciences : CMLS
|
July 15, 2024
Truncated tau interferes with the autophagy and endolysosomal pathway and results in lipid accumulation
Saskia J Pollack, Dina Dakkak, Tong Guo, et al.
Acta Neuropathologica Communications
|
May 20, 2016
Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer's disease
Dawn H W Lau, Marte Hogseth, Emma C Phillips, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
July 5, 2003
Presenilin redistribution associated with aberrant cholesterol transport enhances beta-amyloid production in vivo
Mark Burns, Kate Gaynor, Vicki Olm, et al.
Acta Neuropathologica Communications
|
May 8, 2018
A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies
Caterina Giacomini, Chuay-Yeng Koo, Natalia Yankova, et al.
The FEBS Journal
|
June 23, 2011
Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau
Alessia Usardi, Amy M Pooler, Anjan Seereeram, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 79) with videos related to
Sort By:
Page
of 8
Journal of Neurochemistry
|
June 12, 2023
Proteomics of the astrocyte secretome reveals changes in their response to soluble oligomeric Aβ
Vittoria Matafora, Alena Gorb, Fangjia Yang, et al.
Human Molecular Genetics
|
July 5, 2013
Loss of c-Jun N-terminal kinase-interacting protein-1 does not affect axonal transport of the amyloid precursor protein or Aβ production
Alessio Vagnoni, Elizabeth B C Glennon, Michael S Perkinton, et al.
Molecular Brain
|
January 30, 2015
Evidence that the presynaptic vesicle protein CSPalpha is a key player in synaptic degeneration and protection in Alzheimer's disease
Sachin S Tiwari, Marie d'Orange, Claire Troakes, et al.
Iscience
|
June 30, 2025
Alzheimer's disease brain-derived tau extracts show differential processing and transcriptional effects in human astrocytes
Matthew J Reid, Melissa Leija Salazar, Claire Troakes, et al.
Iscience
|
May 7, 2026
Erratum: Alzheimer's disease brain-derived tau extracts show differential processing and transcriptional effects in human astrocytes
Matthew J Reid, Melissa Leija Salazar, Claire Troakes, et al.
Cellular and Molecular Life Sciences : CMLS
|
July 15, 2024
Truncated tau interferes with the autophagy and endolysosomal pathway and results in lipid accumulation
Saskia J Pollack, Dina Dakkak, Tong Guo, et al.
Acta Neuropathologica Communications
|
May 20, 2016
Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer's disease
Dawn H W Lau, Marte Hogseth, Emma C Phillips, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
July 5, 2003
Presenilin redistribution associated with aberrant cholesterol transport enhances beta-amyloid production in vivo
Mark Burns, Kate Gaynor, Vicki Olm, et al.
Acta Neuropathologica Communications
|
May 8, 2018
A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies
Caterina Giacomini, Chuay-Yeng Koo, Natalia Yankova, et al.
The FEBS Journal
|
June 23, 2011
Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau
Alessia Usardi, Amy M Pooler, Anjan Seereeram, et al.
Page
of 8